Lithium-induced nephrogenic diabetes insipidus responsive to desmopressin
Acta Endocrinologica, cilt.15, sa.2, ss.270-271, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Kısa Makale
- Cilt numarası: 15 Sayı: 2
- Basım Tarihi: 2019
- Doi Numarası: 10.4183/aeb.2019.270
- Dergi Adı: Acta Endocrinologica
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.270-271
- Anahtar Kelimeler: desmopressin, diabetes insipidus, lithium, nephrogenic
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Nephrogenic diabetes insipidus (NDI) is the most common renal side effect seen with lithium therapy. Persisting cases after the cessation of the therapy may be seen when lithium therapy is continued for too long. Although desmopressin treatment is not one of the accepted treatment modalities for NDI, there are few reports using desmopressin treatment in unresponsive cases. Herein, we reported the fourth lithium-induced NDI case in the literature responsive to desmopressin therapy.